Crossref
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Biologics: Targets & Therapy · 2009
DOI: 10.2147/btt.2009.3112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics: Targets & Therapy, 2009. Verfasst von Charles Schiffer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schiffer, C. (2009). Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia. Biologics: Targets & Therapy. https://doi.org/10.2147/btt.2009.3112
Vancouver
Schiffer C. Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia. Biologics: Targets & Therapy. 2009. doi:10.2147/btt.2009.3112
BibTeX
@article{Schiffer2009,
author = {Schiffer, Charles},
title = {Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia},
journal = {Biologics: Targets & Therapy},
year = {2009},
doi = {10.2147/btt.2009.3112}
}
EUVIMED